Manayunk resident Rebeca Cruz-Esteves had her first dose of the Pfizer COVID vaccine on March 17. As a young mother in a pandemic, she was hypervigilant about her health: She called her gynecologist ...
About 100 people who have received the one-dose Johnson & Johnson COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barré Syndrome about two weeks after getting their shot, ...
LABEL TO BE PLACED ON THE JOHNSON & JOHNSON SHOT. A NEW WARNING FROM THE FDA ABOUT THE JOHNSON AND JOHNSON COVID VACCINE. FLAGGING IT FOR POTENTLLYIA SLIGHT DEVELOPING THE RISK OF A RARE NEUROLOGICAL ...
HOUSTON -- A Houston woman spent 22 days in the hospital suffering from a rare disorder known as Guillain-Barré that she said her doctor determined was brought on as a result of a very rare reaction ...
WASHINGTON (AP) — Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday. The Centers for ...
Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination based ...
About 100 people who have received the one-dose Johnson & Johnson COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barré Syndrome about two weeks after getting their shot, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results